Gene therapy against neurological insults: Sparing neurons versus sparing function

Trends in Neurosciences

Volumn 24, Issue 12, 2001, Pages 695-700

  Dumas, Theodore C ^a   Sapolsky, Robert M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR; BIOCHEMISTRY; CELL FUNCTION; CELL TYPE; COGNITION; DISEASE SEVERITY; GENE TARGETING; GENE THERAPY; LATENT PERIOD; MORPHOLOGY; NERVE CELL; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

ANIMALS; GENE THERAPY; HUMANS; NEURODEGENERATIVE DISEASES; NEURONS;

EID: 0035576893     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(00)01956-1     Document Type: Review

References (52)

1. Calcium still center-stage in hypoxic-ischemic neuronal death
2. Etiology and pathogenesis of Parkinson's disease
3. Corticospinal tract regrowth
4. Energetics in the pathogenesis of neurodegenerative diseases
5. Gene therapy using viral vectors for acute neurologic insults
6. Gene therapies that enhance hippocampal neuron survival after an excitotoxic insult are not equivalent in their ability to maintain synaptic transmission
7. An adenoviral vector expressing the glucose transporter protects cultured striatal neurons from 3-nitropropionic acid
8. Sparing of neuronal function postseizure with gene therapy
9. Genetically modified fibroblasts producing NGF protect hippocampal neurons after ischemia in the rat
10. Inhibition of caspases prevents cell death of hippocampal CA1 neurons, but not impairment of hippocampal long-term potentiation following global ischemia
11. Caspase-3 mediated neuronal death after traumatic brain injury in rats
12. Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus
13. Limitations in the neuroprotective potential of gene therapy with Bcl-2
14. Neuroprotection with herpes simplex vectors expressing virally derived anti-apoptotic agents
15. Herpes simplex virus vectors overexpressing the glucose transporter gene protect against seizure-induced neuron loss
16. Gene transfer of calbindin D28k cDNA via herpes simplex virus amplicon vector decreases cytoplasmic calcium ion response and enhances neuronal survival following glutamatergic challenge but not following cyanide
17. Calbindin overexpression buffers hippocampal cultures from the energetic impairments caused by glutamate
18. Long-term behavioral recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase
19. Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease
20. Viral gene delivery selectively restores feeding and prevents lethality of dopamine-deficient mice
21. Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-OHDA-induced degeneration of neurons in the substantia nigra in vivo
22. Herpes simplex virus vector-mediated expression of bcl-2 protects spinal motor neurons from degeneration following root avulsion
23. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
24. DNA plasmid that codes for human Bcl-2 gene preserves axotomized Clarke's nucleus neurons and reduces atrophy after spinal cord hemisection in adult rats
25. Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis
26. Intercostal nerve implants transduced with an adenoviral vector encoding neurotrophin-3 promote regrowth of injured rat corticospinal tract fibers and improve hindlimb function
27. Adenoviral vector-mediated delivery of neurotrophic factors promotes axonal growth from a schwann cell (SC) graft into the adult rat spinal cord and improves hindlimb function
28. Partial functional recovery of paraplegic rat by adenovirus-mediated gene delivery of constitutively active MEK1
29. Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus
30. Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy
31. Adenovirus-mediated expression of ciliary neurotrophic factor (CTNF) rescues axotomized rat retinal ganglion cells but does not support axonal regeneration in vivo
32. Bcl-2 overexpression per se does not promote regeneration of neonatal crushed optic fibers
33. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease
34. Rescue from death but not from functional impairment: Caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals
35. Selective reduction of hippocampal dentate frequency-potentiation in striatally lesioned rats with impaired place learning
36. Memories of NMDA receptors and LTP
37. Metaplasticity of mossy fiber synaptic transmission involves altered release probability
38. Neuroprotection with Bcl-220-34 peptide against trauma
39. Gene therapy effectiveness differs for cell death and function processing
40. Multi-site partitioned delivery of human tyrosine hydroxylase gene with phenotypic recovery in Parkinsonian rats
41. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain
42. Intrastriatal injection of an adenoviral vector expression glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease
43. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor
44. Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: Intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system
45. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections
46. Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors
47. Adenovirus-mediated transfer of the neurotrophin-3 gene into skeletal muscle of pmn mice: Therapeutic effects and mechanisms of action
48. Modulation of antioxidant defenses during apoptosis
49. The mitochondrial death/life regulator in apoptosis and necrosis
50. Bcl-2 proteins: Regulators of apoptosis or of mitochondrial homeostasis?
51. Neuroprotective potential of a viral vector system induced by a neurological insult
52. Hypoxia-inducible factor-1alpha mediates hypoxia-induced delayed neuronal death that involves p53